Based on the AVEROSS trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention in nonvalvular AF. There is a need to reconsider the benefits of using aspirin ...
Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...
On the basis of these findings, the authors conclude that Doppler-derived E/E' is a useful predictor of clinical outcome in patients with nonvalvular atrial fibrillation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback